Conformations of membrane human immunodeficiency virus (HIV-1) envelope glycoproteins solubilized in Amphipol A18 lipid-nanodiscs.

Autor: Zhang S; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Microbiology, Harvard Medical School, Boston, Massachusetts, USA., Anang S; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Microbiology, Harvard Medical School, Boston, Massachusetts, USA., Zhang Z; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Microbiology, Harvard Medical School, Boston, Massachusetts, USA., Nguyen HT; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Microbiology, Harvard Medical School, Boston, Massachusetts, USA., Ding H; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.; Birmingham Veterans Affairs Medical Center, Research Service, Birmingham, Alabama, USA., Kappes JC; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.; Birmingham Veterans Affairs Medical Center, Research Service, Birmingham, Alabama, USA., Sodroski J; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Microbiology, Harvard Medical School, Boston, Massachusetts, USA.

Publikováno v: Journal of virology [J Virol] 2024 Oct 22; Vol. 98 (10), pp. e0063124. Date of Electronic Publication: 2024 Sep 09.

Engineering immunogens that select for specific mutations in HIV broadly neutralizing antibodies.

Autor: Henderson R; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA.; Department of Medicine, Duke University Medical Center, Durham, NC, USA., Anasti K; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Manne K; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Stalls V; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Saunders C; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Bililign Y; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Williams A; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Bubphamala P; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Montani M; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Kachhap S; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Li J; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Jaing C; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Newman A; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Cain DW; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA.; Department of Medicine, Duke University Medical Center, Durham, NC, USA., Lu X; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Venkatayogi S; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Berry M; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Wagh K; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Korber B; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, USA.; The New Mexico Consortium, Los Alamos, NM, USA., Saunders KO; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA.; Department of Surgery, Duke University Medical Center, Durham, NC, USA., Tian M; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.; Department of Genetics, Harvard Medical School, Boston, MA, USA., Alt F; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.; Department of Genetics, Harvard Medical School, Boston, MA, USA., Wiehe K; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA.; Department of Medicine, Duke University Medical Center, Durham, NC, USA., Acharya P; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA.; Department of Surgery, Duke University Medical Center, Durham, NC, USA.; Department of Biochemistry, Duke University, Durham, NC, USA., Alam SM; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA.; Department of Medicine, Duke University Medical Center, Durham, NC, USA.; Department of Pathology, Duke University School of Medicine, Durham, NC, USA., Haynes BF; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA. barton.haynes@duke.edu.; Department of Immunology, Duke University Medical Center, Durham, NC, USA. barton.haynes@duke.edu.

Publikováno v: Nature communications [Nat Commun] 2024 Nov 03; Vol. 15 (1), pp. 9503. Date of Electronic Publication: 2024 Nov 03.

Sodium-dependent phosphate transporter PiT1/SLC20A1 as the receptor for the endogenous retroviral envelope syncytin-B involved in mouse placenta formation.

Autor: Mousseau G; Viroxis, Institut Gustave Roussy, Villejuif, France., Préault N; Unité Physiologie et Pathologie Moléculaires des Rétrovirus Endogènes et Infectieux, CNRS UMR 9196, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France., Souquere S; AMMICA UMS-3655, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France., Bireau C; Unité Physiologie et Pathologie Moléculaires des Rétrovirus Endogènes et Infectieux, CNRS UMR 9196, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France., Cassonnet P; Unité de Génétique Moléculaire des Virus à ARN, Département Virologie, Institut Pasteur, Paris, France.; UMR3569, Centre National de la Recherche Scientifique, Paris, France.; Université Paris Diderot, Sorbonne Paris Cité, Paris, France., Bacquin A; Viroxis, Institut Gustave Roussy, Villejuif, France., Beck L; Nantes Université, CNRS, Inserm, l'Institut du Thorax, Nantes, France., Pierron G; Unité Physiologie et Pathologie Moléculaires des Rétrovirus Endogènes et Infectieux, CNRS UMR 9196, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France., Jacob Y; Unité de Génétique Moléculaire des Virus à ARN, Département Virologie, Institut Pasteur, Paris, France.; UMR3569, Centre National de la Recherche Scientifique, Paris, France.; Université Paris Diderot, Sorbonne Paris Cité, Paris, France.; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts, USA., Dupressoir A; Unité Physiologie et Pathologie Moléculaires des Rétrovirus Endogènes et Infectieux, CNRS UMR 9196, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France., Heidmann T; Viroxis, Institut Gustave Roussy, Villejuif, France.; Unité Physiologie et Pathologie Moléculaires des Rétrovirus Endogènes et Infectieux, CNRS UMR 9196, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France.

Publikováno v: Journal of virology [J Virol] 2024 Oct 22; Vol. 98 (10), pp. e0091524. Date of Electronic Publication: 2024 Sep 17.

Reduced syncytin-1 regulates trophoblast invasion and apoptosis in preeclampsia.

Autor: Wang YN; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Shantou University Medical College, China; Department of Histology and Embryology, Shantou University Medical College, China., Chen XL; Department of Histology and Embryology, Shantou University Medical College, China., Yang J; Department of Histology and Embryology, Shantou University Medical College, China., Gong XX; Department of Histology and Embryology, Shantou University Medical College, China., Zhang HF; Department of Histology and Embryology, Shantou University Medical College, China., Zhang YM; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Shantou University Medical College, China., Zeng DF; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Shantou University Medical College, China., Chen PS; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Shantou University Medical College, China. Electronic address: f2fckcps@163.com., Chen HB; Department of Histology and Embryology, Shantou University Medical College, China.

Publikováno v: Placenta [Placenta] 2024 Sep 26; Vol. 155, pp. 32-41. Date of Electronic Publication: 2024 Jul 29.

TFEB controls expression of human syncytins during cell-cell fusion.

Autor: Esbin MN; Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, California 94720, USA; jmlim@berkeley.edu meagan_esbin@berkeley.edu., Dahal L; Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, California 94720, USA., Fan VB; Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, California 94720, USA., McKenna J; Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, California 94720, USA., Yin E; Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, California 94720, USA., Darzacq X; Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, California 94720, USA., Tjian R; Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, California 94720, USA; jmlim@berkeley.edu meagan_esbin@berkeley.edu.; Howard Hughes Medical Institute, University of California, Berkeley, California 94720, USA.

Publikováno v: Genes & development [Genes Dev] 2024 Sep 19; Vol. 38 (15-16), pp. 718-737. Date of Electronic Publication: 2024 Sep 19.